Prevalence and predictors of reduced work productivity in patients with psoriatic arthritis

Clinical and Experimental Rheumatology

Volumn 32, Issue 3, 2014, Pages 342-348

  Kennedy, Matthew ^a   Papneja, Anjali ^a   Thavaneswaran, Arane ^a   Chandran, Vinod ^a   Gladman, Dafna D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Disease activity; Employment; Presenteeism; Psoriatic arthritis; Quality of life; Work

Indexed keywords

BIOLOGICAL PRODUCT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL COMORBIDITY INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PRODUCTIVITY; PSORIASIS AREA AND SEVERITY INDEX; PSORIATIC ARTHRITIS; QUALITY OF LIFE; QUESTIONNAIRE; QUESTIONNAIRE FOR THE ASSESSMENT OF WORK RELATED FACTOR; SEX DIFFERENCE; WORK LIMITATIONS QUESTIONNAIRE; WORKING TIME;

ABSENTEEISM; ADULT; AGED; ARTHRITIS, PSORIATIC; COMORBIDITY; EFFICIENCY; EMPLOYMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84901829521     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. MEASE PJ: Psoriatic arthritis assessment and treatment update. Curr Opin Rheumatol 2009; 21: 348-55.
2. CHANDRAN V, RAYCHAUDHURI SP: Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010; 34: J314-J321.
3. KANE D, STAFFORD L, BRESNIHAN B, FITZGERALD O: A prospective, clinical and radiological study of early psoriatic arthritis: An early synovitis clinic experience. Rheumatology (Oxford) 2003; 42: 1460-8.
4. McHUGH NJ, BALACHRISHNAN C, JONES SM: Progression of peripheral joint disease in psoriatic arthritis: A 5-yr prospective study. Rheumatology (Oxford) 2003; 42: 778-83.
5. HUSTED JA, TOM BD, FAREWELL VT, SCHENTAG CT, GLADMAN DD: Description and prediction of physical functional disability in psoriatic arthritis: A longitudinal analysis using a Markov Model approach. Arthritis Rheum 2005; 53: 404-9.
6. SOKOLL KB, HELLIWELL PS: Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001; 28: 1842-6.
7. ZINK A, THIELE K, HUSCHER D et al.: Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 2006; 33: 86-90.
8. SALAFFI F, CAROTTI M, GASPARINI S, INTORCIA M, GRASSI W: The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: A comparison with a selected sample of healthy people. Health Qual Life Outcomes 2009; 18; 7: 25.
9. HUSTED JA, GLADMAN DD, FAREWELL VT, COOK RJ: Health-related quality of life of patients with psoriatic arthritis: A comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001; 45: 151-8.
10. HUSTED JA, GLADMAN DD, FAREWELL VT, LONG JA, COOK RJ: Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 1997; 24: 511-7.
11. KAVANAUGH A, ANTONI C, MEASE P et al.: Effect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritis. J Rheumatol 2006; 33: 2254-9.
12. WALLENIUS M, SKOMSVOLL JF, KOLDINGSNES W et al.: Work disability and health-related quality of life in males and females with psoriatic arthritis. Ann Rheum Dis 2009; 68: 685-9.
13. ZHU TY, TAM LS, LEUNG YY et al.: Socio-economic burden of psoriatic arthritis in Hong Kong: Direct and indirect costs and the influence of disease pattern. J Rheumatol 2010; 37: 1214-20.
14. BRODSZKY V, BALINT P, GEHER P et al.: Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment. Rheumatol Int 2009; 30: 199-205.
15. HUSCHER D, MERKESDAL S, THIELE K et al.: Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 2006; 65: 1175-83.
16. LI X, GIGNAC MA, ANIS AH: The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med Care 2006; 44: 304-10.
17. SCHULTZ AB, EDINGTON DW: Employee health and presenteeism: A systematic review. J Occup Rehabil 2007; 17: 547-79.
18. GLADMAN DD, ACCLAIM Study InvesStiIgatorsS, SAMPALIS JS, ILLOUZ O, GUERETTE B: Responses to adalimumab in patients with active psoriatic arthritis who have not adequately responded to prior therapy: Effectiveness and safety results from an open-label study. J Rheumatol 2010; 37: 1898-906.
19. ROY JS, DESMEULES F, MacDERMID JC: Psychometric properties of presenteeism scales for musculoskeletal disorders: A systematic review. J Rehabil Med 2011; 43: 23-31.
20. LERNER D, AMICK BC, 3rd, ROGERS WH, MALSPEIS S, BUNGAY K, CYNN D: The work limitations questionnaire. A Self-Administered Instrument for Assessing On-The-Job Work Disability. Med Care 2001; 39: 72-85.
21. GLADMAN DD, SAMPALIS JS, MARTEL MJ, GOOCH KL, WONG R, GUERETTE B: Reliability and validity of the work limitations questionnaire (WLQ) and impact of adalimumab (HUMIRA) on presenteeism for patients with psoriatic arthritis (PsA). Arthritis Rheum 2008; 58 (Suppl. 9): S202.
22. WALKER N, MICHAUD K, WOLFE F: Work limitations among working persons with rheumatoid arthritis: Results, reliability, and validity of the work limitations questionnaire in 836 patients. J Rheumatol 2005; 32: 1006-12.
23. LERNER D, REED JI, MASSAROTTI E, WESTER LM, BURKE TA: The work limitations questionnaire's validity and reliability among patients with osteoarthritis. J Clin Epidemiol 2002; 55: 197-208.
24. TAYLOR WJ, GLADMAN DD, HELLIWELL PS, MARCHESONI A, MEASE P, MIELANTS H: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73.
25. LERNER D, CHANG H, ROGERS WH, BENSON C, SCHEIN J, ALLAIRE S: A method for imputing the impact of health problems on at-work performance and productivity from available health data. J Occup Environ Med 2009; 51: 515-24.
26. GOTTLIEB AB, CHAUDHARI U, BAKER DG, PERATE M, DOOLEY LT: The national psoriasis foundation psoriasis score (NPF-PS) system versus the psoriasis area severity index (PASI) and physician's global assessment (PGA): A comparison. J Drugs Dermatol 2003; 2: 260-6.
27. FORTIN M, HUDON C, DUBOIS MF, ALMIRALL J, LAPOINTE L, SOUBHI H: Comparative assessment of three different indices of multimorbidity for studies on health-related quality of life. Health Qual Life Outcomes 2005; 23; 3: 74.
28. GROLL DL, TO T, BOMBARDIER C, WRIGHT JG: The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005; 58: 595-602.
29. WOLFE F, MICHAUD K, CHOI HK, WILLIAMS R: Household income and earnings losses among 6,396 persons with rheumatoid arthritis. J Rheumatol 2005; 32: 1875-83.
30. ROHEKAR S, POPE J: Assessment of work disability in seronegative spondyloarthritis. Clin Exp Rheumatol 2010; 28: 35-40.
31. HUSTED JA, TOM BD, SCHENTAG CT, FAREWELL VT, GLADMAN DD: Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis 2009; 68: 1553-8.
32. KHRAISHI M, MacDONALD D, RAMPAKAKIS E, VAILLANCOURT J, SAMPALIS JS: Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts. Clin Rheumatol 2011; 30: 877-85.
33. GLADMAN DD, THAVANESWARAN A, CHANDRAN V, ZUMMER M: Psoriatic arthritis (PsA) in Canadian clinical practice: the PsA assessment in rheumatology (PAIR). J Rheumatol 2012; 39: 1850-3.